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Objective. To examine the productivity of patients with scleroderma (systemic sclerosis [SSc]) both outside of and within
the home in a large observational cohort.
Methods. One hundred sixty-two patients completed the Work Productivity Survey. Patients indicated whether or not
they were employed outside of the home, how many days per month they missed work (employment or household work)
due to SSc, and how many days per month productivity was decreased by >50%. Patients also completed other
patient-reported outcome measures. We developed binomial regression models to assess the predictors of days missed
from work (paid employment or household activities). The covariates included: type of SSc, education, physician and
patient global assessments, Health Assessment Questionnaire (HAQ) disability index (DI), Functional Assessment of
Chronic Illness Therapy–Fatigue, and Center of Epidemiologic Studies Depression Scale Short Form.
Results. The mean age of patients was 51.8 years and 52% had limited cutaneous SSc. Of the 37% of patients employed
outside of the home, patients reported missing 2.6 days per month of work and had 2.5 days per month of productivity
reduced by half. Of the 102 patients who were not employed, 39.4% were unable to work due to their SSc. When we
assessed patients for household activities (n  162), patients missed an average of 8 days of housework per month and
had productivity reduced by an average of 6 days per month. In the regression models, patients with lower education and
poor assessment of overall health by a physician were more likely to miss work outside of the home. Patients with limited
cutaneous SSc and high HAQ DI scores were more likely to miss work at home.
Conclusion. SSc has a major impact on productivity at home and at work. Nearly 40% of patients reported disability due
to their SSc.
INTRODUCTION
Systemic sclerosis (SSc; scleroderma) can be associated
with functional disability and internal organ damage (1).
SSc causes substantial economic burden as assessed by
direct and indirect costs related to SSc (1,2). Previous
studies have largely focused on work disability associated
with SSc (3,4). However, many patients continue to work
despite their SSc and may require taking days off or re-
ducing their productivity at work due to illness ﬂare or
medical appointments (5). Work productivity assesses the
economic productivity of a person, described in terms of
costs, proﬁts, or output targets (5), and has an impact on
the individual, the employer, and society. It can be further
divided into absenteeism (full days of work missed due to
disability) and presenteeism (days with work productivity
reduced by 50%) (5–7). In addition, productivity as-
sesses the impact of an illness on a patient’s ability to do
household activities.
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Participants of Outcome Measures in Rheumatology 9
(OMERACT 9) strongly endorsed work productivity as an
outcome measure in different arthritides (5). The Work
Productivity Survey-Rheumatoid Arthritis (WPS-RA) is a
validated instrument that was initially developed for rheu-
matoid arthritis (RA) (8) and has been used in a longitu-
dinal clinical trial in RA (7). The self-reported question-
naire is based on self-report with a recall period of 1 month
and assesses productivity at work and at home (8). The
WPS-RA was found to meet OMERACT ﬁlters of truth,
discrimination, and feasibility at the OMERACT 9 confer-
ence (5). We assessed productivity outside of and within
the home using the modiﬁed WPS-RA in a large observa-
tional study in patients with SSc. The objectives of this
study were to 1) assess the prevalence of productivity
outside of and within the home in patients with SSc, 2)
determine the predictors of decreased productivity outside
of and within the home in SSc, and 3) assess the preva-
lence and predictors of self-reported SSc-associated dis-
ability.
PATIENTS AND METHODS
Patient sample. One hundred sixty-two participants
with SSc participated in the University of California, Los
Angeles (UCLA) Scleroderma Quality of Life study (9). The
participants are patients who were evaluated for their SSc
at the UCLA Scleroderma Program. Patients underwent
clinical history and physical examination to determine the
type of SSc (limited cutaneous SSc [lcSSc], diffuse cuta-
neous SSc [dcSSc], or overlap syndrome) and physician
global assessment. Patients completed sociodemographic
information (age, sex, ethnicity, and level of education),
the patient global assessment, and the WPS. All data were
gathered at the same visit for each patient.
Patient-reported measures. The WPS-RA (8) was ini-
tially developed for RA. We modiﬁed the survey by replac-
ing the word “arthritis” with “scleroderma” throughout
the survey so that we could assess the impact of SSc on
productivity within and outside of the home in terms of
daily activities. The survey is based on self-report, with a
recall period of 1 month. It consists of 9 questions. The
ﬁrst question assesses employment status, type of job for
the employed (nonmanual, manual, or mixed manual/non-
manual), and the status of those unemployed (homemaker,
retired, student, unable to work due to SSc, unable to work
due to non-SSc health problems, or other, i.e., volunteer).
The next 3 questions only apply to employed patients and
assess absenteeism (full days of work missed due to SSc),
presenteeism (days with work productivity reduced by
50%), and how much SSc interfered with work produc-
tivity on a scale of 0–10, where 0  “no interference” and
10  “complete interference.”
The last 5 questions of the survey are applicable to all
patients and assess productivity limitations at home doing
household work (2 questions) and participation in family,
social, or leisure activities (3 questions). The WPS makes
the assumption that all patients, employed or not em-
ployed, participate in household work. Patients are asked
the following: number of days with no household work
done due to SSc; number of days home productivity was
reduced by 50% due to SSc; number of days of family,
social, or leisure activities that were missed due to SSc;
number of days outside hired help (i.e., housekeeper) was
needed; and how much SSc interfered with household
productivity on a scale of 0–10, where 0  “no interfer-
ence” and 10  “complete interference.”
The Center for Epidemiologic Studies Short Depression
Scale Short Form (CES-D-10) is a 10-item instrument that
assesses depressive symptoms (10). The occurrence of
each depressive symptom during the past week is rated on
a scale from 0–3, with the total score ranging from 0–30. A
score of 10 is indicative of depressed mood. The 10-item
short form was used because it has shown good predictive
accuracy when compared to the full-length questionnaire
(10) and has been used in SSc studies (9).
The Health Assessment Questionnaire (HAQ) disability
index (DI) is a self-reported 20-item musculoskeletal-tar-
geted questionnaire that assesses the impact of disease on
physical function and disability (11). The questionnaire
contains 20 items divided into 8 domains that measure
dressing and grooming, arising, eating, walking, hygiene,
reach, and grip, and common daily activities. Patients
indicate the degree of difﬁculty they had in the past week
in each of the domains on a scale of 0 (without difﬁculty)
to 3 (unable to do). HAQ DI scores from 0–1 represent no
to mild functional difﬁculty, 1–2 represent moderate func-
tional difﬁculty, and 2–3 indicate severe functional difﬁ-
culty (12).
The Functional Assessment of Chronic Illness Therapy–
Fatigue (FACIT-F) is a 13-item questionnaire that assesses
fatigue severity and impact on a scale of 0–4. Total scores
range from 0–52; lower scores indicate more severe fatigue
(13).
The patient overall health assessment is a 1-item ques-
tion that assesses general health status by asking patients,
“In general, how would you say your health is?” Re-
sponses are rated on a scale of 1–5, where 1  “excellent”
health and 5 “poor” health. The physician assessment of
overall health is a 1-item question that assesses the overall
health of a patient in the last week. Physicians are asked,
“On a scale of 0–10, how was your patient’s overall health
in the last week?” Responses are rated on a scale of 0–10,
where 0  “excellent” health and 10  “extremely poor”
health.
Statistical analysis. Mean  SD scores and proportions
were calculated for all instruments. Days missed at work
and days missed at home were treated as count data and
Signiﬁcance & Innovations
● Systemic sclerosis (SSc; scleroderma) has a major
impact on productivity at home and at work.
● Approximately 40% of patients are disabled due to
their SSc in a large observational cohort.
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modeled using negative binomial regression. Negative bi-
nomial regression is a more ﬂexible alternative to Poisson
regression, which requires that the variance of the out-
come measure at each ﬁxed level of the covariates be equal
to the mean (14). Variables that may be associated with
loss of productivity at home and outside of the home were
included in the bivariate analyses. These variables were
chosen based on previously published data (2,3) and in-
vestigators’ opinions of which are relevant to productivity.
Explanatory variables for all models examined were age,
sex (reference group: male), type of SSc (reference group:
overlap), education, physician and patient overall health,
HAQ DI, FACIT-F, and CES-D-10. Variables signiﬁcant at P
values less than 0.10 in either model were entered into
multivariable negative binomial regression models to as-
sess predictors of days missed at work and days missed at
home.
We also explored the predictors of disability due to SSc.
We compared the group who reported that they are unable
to work due to their SSc to patients who were currently
employed. Explanatory variables for all models examined
were age, sex (reference group: male), type of SSc (refer-
ence group: overlap), education, physician and patient
overall health, HAQ DI, FACIT-F, and CES-D-10. Variables
signiﬁcant at P values less than 0.10 were entered into the
multivariable logistic model. All analyses were performed
on Stata, version 10.2, and P values less than 0.05 were
indicative of statistical signiﬁcance.
Labor statistics. We calculated how the loss of produc-
tivity at work translated into 2010 US dollars. The US
Department of Labor, Bureau of Labor Statistics recently
published the median weekly earnings of employees ages
25 years and older by sex and level of education in 2010
(15). As an example, a woman with less than a high school
diploma earned a median income of $377 a week and a
man with less than a high school diploma earned a median
income of $485 a week, whereas a woman with a bache-
lor’s degree earned a median weekly income of $920 and a
man earned $1,138. These weekly median values were
multiplied by 52 and then divided by 12 (4.33) to obtain
monthly estimated median earnings. We then calculated
the estimated earnings lost due to work missed by multi-
plying estimated median earnings by the fraction of days
of work missed per month to the total number of work days
per month. As an example, for a woman earning a median
income of $377 a week, we calculated monthly income by
multiplying $377  4.33  $1,632. Taking (52  5)/12 
22 to be the average number of work days per month, if this
person missed 1 day per month, then the person lost an
estimated $1,632  (1/22)  $74 a month.
Table 1. Clinical characteristics of the study participants*
Variables
Total sample
(n  162)
lcSSc
(n  84)
dcSSc
(n  67)
Age, mean  SD years 51.8  14.2 56.0  14.1 48.3  12.9†
Female sex, no. (%) 131 (81) 70 (83.3) 51 (76.1)
Type of SSc, no. (%)
lcSSc 84 (51.9)
dcSSc 67 (41.4)
Overlap 11 (6.8)
Disease duration, mean  SD years 7.6  8.2 9.3  9.1 5.6  6.8†
Race, no. (%)‡
White 110 (69.1) 64 (79.0) 40 (60.0)
African American 10 (6.3) 3 (3.7) 7 (10.5)
Asian 21 (13.2) 6 (7.4) 14 (21.0)
American Indian/Alaskan native 4 (2.5) 3 (3.7) 0 (0)
More than one 10 (6.3) 4 (4.9) 4 (6.0)
Unknown 4 (2.5) 1 (1.3) 2 (3)
Education, no. (%)
Grade 8 or less 5 (3.1) 1 (1.2) 4 (6.0)
Grade 9–11 2 (1.3) 0 (0) 1 (1.5)
High school graduate 18 (11.3) 11 (13.4) 7 (10.5)
Some college 56 (35) 30 (36.6) 22 (32.8)
College graduate 36 (22.5) 17 (20.7) 17 (25)
One or more years postcollege 43 (26.9) 23 (28) 16 (24)
CES-D-10 score, mean  SD (range 0–30)§ 8.4  5.9 8.1  6.6 8.7  5.1
Depressed mood (CES-D score 10), no. (%) 58 (35.4) 24 (29.0) 28 (41.8)
HAQ DI score, mean  SD (range 0–3)§ 0.9  0.7 0.7  0.6 1.2  0.7†
FACIT-F score, mean  SD (range 0–52)¶ 31.7  12.6 34.2  12.1 28.6  12.8
* lcSSc  limited cutaneous systemic sclerosis; dcSSc  diffuse cutaneous systemic sclerosis; CES-D-10  Center for Epidemiologic Studies
Depression Scale Short Form; HAQ  Health Assessment Questionnaire; DI  disability index; FACIT-F  Functional Assessment of Chronic Illness
Therapy–Fatigue Scale.
† P  0.05.
‡ One patient with missing data.
§ Higher score denotes poor health-related quality of life (HRQOL).
¶ Lower score denotes poor HRQOL.
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RESULTS
The mean  SD age of the patients was 51.8  14.2 years
and the mean  SD disease duration was 7.6  8.2 years
(Table 1). Eighty-one percent of our cohort was female,
69% were white, 52% had lcSSc, 41% had dcSSc, and 7%
had overlap syndrome. Our patient cohort was well edu-
cated; 49.4% of our patients had at least a college degree.
Patients with lcSSc were older in reported age (mean 56.0
versus 48.3 years; P  0.05) and had a longer disease
duration (mean 9.3 versus 5.6 years; P  0.05). Patients
with dcSSc had greater functional disability (1.3 versus
0.7; P  0.05). There were no other differences in clinical
characteristics (Table 1).
Sixty patients (37%) were employed outside of the
home, with a majority employed in nonmanual work
(68%) (Table 2). Of the 102 patients who were not em-
ployed outside of the home, 39.4% reported that they were
unable to work due to SSc-related health problems (SSc-
related work disability group), 8.1% were unable to work
due to non-SSc health problems, 12.1% were homemak-
ers, 28.3% were retired, and 5.1% were students. A higher
proportion of patients with dcSSc (76.2%) were employed
in nonmanual work compared to lcSSc (62.9%; P  not
signiﬁcant [NS]).
Work productivity in the employed patients. Employed
patients (n  60) reported missing 2.6 days per month of
work (absenteeism), had 2.5 days per month of productiv-
ity reduced by half (presenteeism), and had 2.2 days per
month where SSc interfered with their work (Table 2).
Twenty-four (41%) of the 58 (2 patients who were em-
ployed did not provide these data) employed patients
missed at least 1 day of work per month. Patients with
lcSSc reported missing more days of work (3.5 versus 1.5
days) and having more days with decreased productivity
(3.4 versus 1.2 days) when compared to patients with
diffuse disease (P  NS) (Table 2). We further compared
patients doing manual/mixed work versus nonmanual
work. Patients doing manual/mixed work had greater ab-
senteeism (mean 3.95 days versus 2.03 days) and presen-
teeism (mean 4.0 days versus 1.74 days) compared to those
doing nonmanual work, but this was not statistically sig-
niﬁcant (P  0.05).
We explored the predictors of loss of productivity in the
Table 2. Descriptive statistics of the productivity at home and work (n  162)*
Total
sample lcSSc dcSSc
Employed outside of the home
N 60† 35 21
Nonmanual, no. (%) 41 (68.3) 22 (62.9) 16 (76.2)
Mixed, no. (%) 16 (26.7) 11 (31.4) 4 (19.1)
Manual, no. (%) 3 (5.0) 2 (5.7) 1 (4.8)
Work days missed (absenteeism), mean  SD 2.6  6.3 3.5  7.8 1.5  2.9
Days with work productivity reduced by 50% (presenteeism),
mean  SD
2.5  6.1 3.4  7.5 1.2  2.6
Days of SSc interference with work productivity, mean  SD 2.2  2.9 2.1  3.0 2.7  2.9
Not employed outside of the home
N 99‡ 43 46
Homemaker, no. (%) 12 (12.1) 8 (18.6) 4 (8.7)
Retired, no. (%) 28 (28.3) 16 (37.2) 11 (23.9)
Student, no. (%) 5 (5.05) 3 (7.0) 1 (2.2)
Unable to work due to scleroderma, no. (%) 39 (39.4) 10 (23.3) 24 (52.2)
Unable to work due to nonscleroderma health problems,
no. (%)
8 (8.1) 4 (9.3) 3 (6.5)
Other (i.e., volunteer work), no. (%) 4 (4.0) 2 (4.7) 1 (2.2)
Reported 1 category, no. (%)§ 3 (3.0) 0 (0.0) 2 (4.3)
All patients
N 164 83 67
Household work days missed, mean  SD 8.0  10.6 6.2  9.4 10.9  11.8
Days with household work productivity reduced by 50%,
mean  SD
6.0  9.7 5.5  9.5 7.3  10.7
Days with family, social, and leisure activities missed,
mean  SD
2.5  5.5 2.4  5.6 2.7  5.8
Days with outside hired help due to SSc, mean  SD 2.0  5.0 1.4  4.0 2.7  6.2
Days of SSc interference with household work productivity,
mean  SD
4.0  3.4 3.4  3.3 5.1  3.5¶
* lcSSc  limited cutaneous systemic sclerosis (scleroderma); dcSSc  diffuse cutaneous systemic sclerosis.
† Four patients had overlap SSc.
‡ Three patients did not report their status.
§ One patient reported being retired and unable to work due to SSc; 1 patient reported being a student, unable to work due to SSc, unable to work due
to non-SSc health problems, and unable to work due to other reasons (i.e., volunteer work); and 1 patient reported being unable to work due to SSc
and unable to work due to non-SSc health problems.
¶ P  0.05.
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work place. In the univariate models, patients with a
higher physician assessment of overall patient health (in-
dicating poor overall health), a higher patient assessment
of overall health (indicating poor health), higher HAQ DI
and CES-D-10 scores (indicating greater functional and
depressed mood, respectively), lower FACIT-F scores (in-
dicating more fatigue), and lower education were more
likely to miss work due to their SSc (Table 3). In the
multivariate regression model, patients with lower educa-
tion and poor health on physician assessment were more
likely to miss work outside of the home (Table 4).
Household productivity in all patients. When assessing
the entire patient population (n 162), patients missed an
average of 8 days of housework per month and had pro-
ductivity reduced by more than 50% on 6 additional days
per month (Table 2). SSc also had an impact on family and
social activities, where patients missed an additional 2.5
days per month. Patients with lcSSc missed less days of
household work than their dcSSc counterparts (6.2 versus
10.9 days; P  NS) and had less days where their SSc
interfered with household work (3.4 versus 5.1 days; P 
0.05). Patients who were not employed missed more days
of household work per month (8.9 days/month) than those
who were employed (6.4 days/month; P  NS).
In the univariate models, patients with poor overall
health on physician assessment and patient assessment,
higher HAQ DI (indicating more functional disability) and
CES-D-10 scores (indicating greater depressed mood), and
lower FACIT-F scores (indicating more fatigue) were likely
to miss household work due to their SSc (Table 3). In the
multivariate models, patients with lcSSc and high HAQ DI
scores were more likely to miss work at home (Table 4).
For example, for every increase in HAQ DI score by 1.0
Table 3. Univariate analysis*
Work missed last month
(n  58)†
Household work missed last
month (n  161)‡
Unadjusted
coefﬁcient P
Unadjusted
coefﬁcient P
Age, years 0.03 0.201 0.01 0.423
Male or female 1.10 0.186 0.37 0.364
lcSSc§ 0.95 0.494 0.54 0.421
dcSSc§ 0.14 0.925 1.11 0.099
Disease duration, years 0.01 0.828 0.01 0.550
Education level 1.32  0.001 0.04 0.780
Physician assessment 0.58 0.002 0.22 0.010
Patient global assessment¶ 1.96 0.011 1.62  0.001
HAQ DI 1.74 0.011 1.16  0.001
FACIT-F 0.10 0.001 0.07  0.001
CES-D-10 0.20 0.004 0.08 0.004
* lcSSc  limited cutaneous systemic sclerosis; dcSSc  diffuse cutaneous systemic sclerosis; HAQ  Health Assessment Questionnaire; DI 
disability index; FACIT-F  Functional Assessment of Chronic Illness Therapy–Fatigue Scale; CES-D-10  Center for Epidemiologic Studies
Depression Scale Short Form.
† Two patients had missing data on all of the outcome variables.
‡ One patient had missing data on all of the outcome variables.
§ Reference group: overlap syndrome.
¶ Patient global assessment, where 1  excellent/very good/good and 2  fair/poor.
Table 4. Multivariate regression models for productivity at work and home*
Work missed last month
(n  49; pseudo R2  0.15)
Household work missed last
month (n 135; pseudo R2  0.05)
Coefﬁcient P Coefﬁcient P
lcSSc† 0.42 0.742 1.64 0.032
dcSSc† 1.33 0.317 1.10 0.143
Education level 0.96 0.014 0.14 0.305
Physician assessment 0.50 0.026 0.04 0.669
Patient global assessment‡ 0.84 0.300 0.91 0.073
HAQ DI 0.07 0.929 1.03  0.001
FACIT-F 0.04 0.420 0.03 0.097
CES-D-10 0.02 0.780 0.04 0.187
* lcSSc  limited cutaneous systemic sclerosis; dcSSc  diffuse cutaneous systemic sclerosis; HAQ  Health Assessment Questionnaire; DI 
disability index; FACIT-F  Functional Assessment of Chronic Illness Therapy–Fatigue Scale; CES-D-10  Center for Epidemiologic Studies
Depression Scale Short Form.
† Reference group: overlap syndrome.
‡ Patient global assessment, where 1  excellent/very good/good and 2  fair/poor.
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unit, the household productivity decreased by 1 day after
controlling for covariates.
SSc-related work disability. Thirty-nine patients re-
ported disability due to their SSc. We explored the predic-
tors of their disability when compared to patients who
were employed. In the univariate model, signiﬁcant pre-
dictors included lower education level, poor overall health
on physician and patient assessments, higher HAQ DI
scores, lower FACIT-F scores, and higher CES-D-10 scores
(Table 5). In the multivariate model, higher HAQ DI scores
were associated with greater odds of disability due to SSc,
and higher education level was associated with greater
odds of being employed.
Labor statistics in our cohort. Using recently published
labor statistics, 41% of employed patients in our cohort
missed at least 1 day of work per month, resulting in a
mean income loss of $897 (range $127–2,792) per month.
Patients with SSc-related disability (39.4%) had a mean 
SD income loss of $3,576.90  $1,302.80 per month.
DISCUSSION
SSc is a chronic disease with marked decrements in func-
tional disability and health-related quality of life that re-
sults in a signiﬁcant burden to society (16). Our study
shows that a lower education level and greater physician
assessment of overall health are predictors of decreased
productivity at work, lcSSc and higher HAQ DI score are
associated with decreased home productivity, and lower
education level and higher HAQ DI score are associated
with SSc-related disability.
Although to our knowledge there are no studies that
examine the predictors of decreased productivity in SSc
using validated instruments, there have been studies in
other rheumatic diseases. Kavanaugh et al used the
WPS-RA and assessed productivity in RA in a clinical
trial, and showed that impairment in physical function in
RA negatively affects patients’ productivity; patients have
a limited ability to perform household and family activi-
ties and are dependent on outside help (7). Other studies
have assessed productivity in different arthritides and are
brieﬂy discussed by Beaton and colleagues as proceedings
from OMERACT 9 (5).
Previous studies have also shown that there is a substan-
tial economic burden associated with SSc. The Canadian
Scleroderma Research Group estimates that SSc costs up
to 1.9 billion US dollars per year across Canada. They
gathered information on the costs of medical care (direct
costs), productivity loss (indirect costs), and total costs
(direct and indirect costs combined) in 457 patients with
SSc. They estimated productivity by using Statistics Can-
ada’s 1998 General Social Survey, which provides detailed
time use of Canadians. Costs of lost productivity related to
unpaid labor contributed $8,070 Canadian dollars per pa-
tient annually in 2007 and accounted for 43.7% of the total
annual cost per patient per year (2). They also found that
high costs in SSc were strongly associated with greater
disease severity, poorer health status, and younger age (2).
The Canadian Scleroderma Research Group also found
that lower education (i.e., no college education) was asso-
ciated with greater costs overall, a trend that we also
observed in our multivariate analyses. Total direct costs
(i.e., the cost of all resources used in the medical treatment
of SSc) were estimated to be $14,959 (in 2007 Canadian
dollars) per patient, with total indirect costs (i.e., produc-
tivity losses or gains attributable to morbidity or premature
mortality from SSc) estimated to be $10,228 per patient (3).
Minier et al also conducted a cross-sectional study in
Hungary to assess the costs of SSc and analyze cost drivers
(16). Only 8.75% of patients were employed full time, with
a majority (48%) receiving a disability allowance. They
showed that direct, indirect, and total costs were higher in
patients with dcSSc compared to lcSSc. This increase in
cost was attributed to a more frequent use of ambulance
Table 5. Predictors of SSc-associated disability*
Univariate model (n  98) Multivariate model (n  81)
Unadjusted
coefﬁcient P
Unadjusted
coefﬁcient P
Age, years 0.99 0.703 – –
Male or female 0.93 0.898 – –
lcSSc† 0.21 0.068 8.0 0.07
dcSSc† 0.90 0.898 1.6 0.5
Disease duration, years 1.03 0.161 – –
Education level 0.50 0.001 0.51 0.01
Physician assessment 1.53 0.001 1.27 0.16
Patient global assessment‡ 10.74 0.025 2.43 0.48
HAQ DI 6.09  0.001 5.22 0.01
FACIT-F 0.92  0.001 0.99 0.89
CES-D-10 1.110 0.008 0.98 0.77
* Comparison is made between those patients reporting systemic sclerosis (SSc) disability versus those who reported being employed. One patient had
missing data on outcome variables and was not included in the univariate analysis. lcSSc  limited cutaneous SSc; dcSSc  diffuse cutaneous SSc;
HAQ  Health Assessment Questionnaire; DI  disability index; FACIT-F  Functional Assessment of Chronic Illness Therapy–Fatigue Scale;
CES-D-10  Center for Epidemiologic Studies Depression Scale Short Form.
† Reference group: overlap syndrome.
‡ Patient global assessment, where 1  excellent/very good/good and 2  fair/poor.
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services by patients with dcSSc. Analysis of cost drivers
demonstrated that disease activity had a signiﬁcant impact
on both direct and indirect costs, whereas disease severity
and patient’s perception of health status correlated only
with direct costs. Hungarian ofﬁcial price, tariffs, and re-
imbursement lists of 2006 were used for cost calculation,
and a validated instrument was not used to assess produc-
tivity. This group of researchers had previously assessed
the cost of RA in Hungary, and found that SSc-related
costs exceed the costs of RA (16).
In our cohort, 41% of employed patients missed at least
1 day of work per month, resulting in an average income
loss of $897 per month or $10,764 per year (assuming
patients missed same number of days each month for 48
weeks). These numbers are very similar to those assessed
by the Canadian Scleroderma Research Group, where loss
of productivity contributed $8,070 Canadian dollars per
patient annually in 2007.
One of the surprising results was a lack of association of
functional disability and productivity at work. Previous
studies in RA have suggested that the HAQ DI is an inde-
pendent predictor of work disability. The HAQ DI has also
been validated for the use of assessing work disability in
SSc (17). In our cohort, low education and physician over-
all health assessment were associated with loss of produc-
tivity at work. It is possible that the lack of correlation with
the HAQ DI is due to a well-educated cohort (68.3% re-
ported nonmanual employment), and physician assess-
ment is a better reﬂection of disease severity and internal
organ involvement. However, the HAQ DI did predict pro-
ductivity at home. We expected dcSSc to be associated
with decreased productivity at home, but noted that lcSSc
was associated with poor productivity. This is likely re-
lated to the mean  SD older age group of our lcSSc
patients of 56.0  14.1 years versus 48.3  12.9 years and
greater disease duration compared to dcSSc (P  0.05).
Our analysis also showed that greater HAQ DI score and
poor education are associated with work disability. Oui-
met et al conducted a cross-sectional study in Canada to
estimate work disability in a cohort of patients with SSc
and showed that HAQ DI score was the most important
independent factor associated with work disability (4).
They also showed that those with work disability had a
longer disease duration and were more likely not to have
completed high school. Hudson et al also conducted a
similar analysis in a cross-sectional multicenter study of
patients from the Canadian Scleroderma Research Group
Registry (3). They found that patients with work disability
were less likely to have education beyond high school and
reported worse physical functioning as assessed by the
HAQ DI.
Patient-reported inability to work had a signiﬁcant im-
pact on the patient’s ability to earn income in our cohort.
Although 84.4% of our patients had some college educa-
tion, 39% of the cohort was unable to work due to SSc.
This translated into a mean loss of $3,576.90 per month or
$42,922.80 for 48 weeks of working time (assuming pa-
tients were disabled for 1 year).
Our study has noteworthy strength. To our knowledge,
our study is the ﬁrst to use a validated instrument to assess
the impact of SSc on productivity outside of and in the
home. We used a validated instrument to meet productiv-
ity in patients with SSc (5). Although we modiﬁed the
instrument by replacing “arthritis” with “scleroderma,”
we believe that this does not diminish the psychometric
properties of the WPS. Other researchers have only used
employment statistics or societal surveys to assess produc-
tivity and have not used patient-reported outcome.
There are certain limitations to our study. Our ﬁndings
are from a single scleroderma center and cannot be applied
to the entire US SSc population. In particular, our patients
were well educated and the societal impact may conse-
quently be higher compared to other patients. Second, our
study utilizes patient-reported outcomes, and we did not
validate each individual patient’s participation in house-
hold activities in face-to-face interviews. As an example,
men who are disabled from work rarely become homemak-
ers, and it is hard to extrapolate what kind of home-related
activities they would participate in. Third, although we
captured patient-reported inability to work based on the
WPS, we did not validate the work disability, as our goal
was to assess work productivity. Fourth, we did not collect
any data on work history before entering into the cohort
and therefore cannot assess if patients left work at some
point prior to our study as a result of their disease. Lastly,
we did not explore the cost of medical care due to SSc in
our patient population.
In conclusion, SSc has a major impact on productivity at
home and at work. Future studies should conﬁrm our
ﬁndings in larger cohorts and develop interventional pro-
grams to improve productivity at home and work in SSc.
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